Myopia management · A flagship specialty
Myopia in children is progressive, but it doesn't have to be. With the right management, we can slow it down and protect their long-term eye health.
Understanding myopia
Myopia occurs when the eyeball grows slightly too long, causing light to focus in front of the retina instead of on it. Distant objects blur while close-up vision stays clear — and every year of unmanaged growth compounds.
The treatments
There's no single right answer — the best approach depends on your child's age, prescription, and lifestyle. Dr. Tran will match the option, or combination, that fits. Whether your child prefers glasses or contacts, there's now an FDA-authorized path to slow progression.
The first FDA-approved soft contact lens for myopia control, for ages 8–12 at initiation. In a 3-year study, MiSight® slowed progression by an average of 59% versus single-vision lenses. Daily disposables — fresh, hygienic, no cleaning.
The first eyeglass lens to earn FDA authorization for slowing pediatric myopia (2025), for ages 6–12 at initiation. In the US clinical trial, Stellest® slowed myopia progression by 71% and eye elongation by 53% over two years versus single-vision lenses, when worn as directed. For families who prefer glasses over contacts.
A nightly low-dose eye drop with a well-studied safety profile that helps slow elongation — used on its own or alongside lenses when Dr. Tran recommends a combined approach.
FDA-authorized options for children with otherwise healthy eyes. Results vary by child and by consistent wear; Dr. Tran will review what to expect at your consultation.
See how they work
Official videos from CooperVision and Essilor explaining how each treatment corrects your child's vision today while slowing myopia progression for the long term.
In clinical studies, children wearing MiSight® showed 59% less myopia progression over three years, and Stellest™ lenses slowed progression by 71% over two years when worn 12 hours a day. Dr. Tran will recommend the right approach for your child at their consultation.
Why it matters
Management slows the rate of change — lower prescriptions and healthier eyes long-term.
Above -6.00D, risks of retinal detachment, macular degeneration, and glaucoma rise dramatically. Management reduces this risk.
Clear vision improves school, sports, and confidence — especially during critical developmental years.
Slower prescription change means less lifelong reliance on strong correction — and lower lifetime cost.
Early, personalized management gives your child the best chance at healthy vision into adulthood.
Results compound: every year of slowed progression protects the decades ahead.
Your visit
Every plan is personalized — clinical assessment, family history, and progression data shape the right approach for your child.
Current prescription, eye health, family history of myopia, and rate of progression.
MiSight® contacts, Stellest® glasses, atropine drops, or a combination — tailored to your child's needs and lifestyle.
Scheduled follow-ups track progression and adjust the plan for the best outcomes over time.
Meet your doctor
Dr. Tran is a myopia management specialist serving the Austin area, fitting MiSight® contacts and Stellest® lenses for children of all ages — and she makes young patients feel completely at ease (ask about the finger puppets).
Families trust Aura
"We've gone there for three years and are happy with the high level of professionalism. The doctor is amazing and takes great care of our daughter's vision."
Google review · Aura Eye Center patient
Brought both my kids here and it was such a good experience. Everyone was patient, kind, and made the visit easy. Highly recommend for families.
I was able to get my daughter an appointment very quickly during Thanksgiving break. The staff and doctor were courteous, helpful and answered all our questions.
Common questions
MiSight® is FDA-approved for ages 8–12 at initiation, and the earlier management starts, the more progression we can prevent. If your child's prescription is climbing yearly, it's time for a consult.
Yes — in clinical trials, kids adapted quickly, and 90% preferred MiSight® over glasses. Daily disposables mean no cleaning routine for parents to police.
Yes. Standard glasses only correct vision, but Essilor Stellest® lenses are FDA-authorized specifically to slow myopia progression in children — the first eyeglass lens to earn that authorization. They're an excellent option for kids who prefer glasses over contacts. Dr. Tran will help you compare Stellest®, MiSight®, and atropine.
Both are FDA-authorized and clinically proven; the right choice depends on your child's age (MiSight® is for ages 8–12 at initiation, Stellest® for ages 6–12), prescription, and whether they're comfortable with contacts. Many families choose based on lifestyle. Dr. Tran walks you through the trade-offs at the consultation. Read our full comparison of MiSight, Stellest, and atropine →
Low-dose atropine has an excellent, well-studied safety profile. Dr. Tran will discuss whether drops, lenses, or both suit your child.
Exams are often covered; management programs are typically self-pay. FSA/HSA funds apply, and we'll walk you through costs before starting.
The earlier myopia management begins, the better the results. Schedule your child's consultation with Dr. Tran today.
Schedule an Appointment Call (512) 885-2134
MiSight® 1 day · Essilor Stellest® · Low-dose atropine · Personalized plans
Related care
Insurance
We verify your benefits before your visit — call (512) 885-2134